# Domperidone in Treating Patients With Gastrointestinal Disorders

> **NCT01696734** · PHASE3 · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 200 (estimated)

## Conditions studied

- Digestive System Disorder
- Dyspepsia
- Esophagitis
- Gastroesophageal Reflux Disease
- Gastroparesis
- Heartburn
- Nausea and Vomiting

## Interventions

- **DRUG:** Domperidone
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT01696734
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2012-10-23
- **Primary completion:** 2027-10-31
- **Final completion:** 2027-10-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01696734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01696734, "Domperidone in Treating Patients With Gastrointestinal Disorders". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01696734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*